Tokyo, Sept. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062933) titled 'Evaluation of a home-use device for male sexual function care after two weeks of use' on Sept. 17.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Historical
Primary Sponsor:
Institute - Japan Clinical Trial Association
Condition:
Condition - Healthy adult male
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Evaluating Changes in Male Sexual Function Using Testing Equipment
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Using the test equipment, continue using it once a day for 15 minutes for two weeks.
Eligibility:
Age-lower limit - 40
years-old
<=
Age-upper limit - Not applicable
Gender - Male
Key inclusion criteria - Subjects who are getting older and are beginning to feel the effects of aging, or who are already feeling them
Key exclusion criteria - 1. Individuals with trauma or infections of the urinary or male reproductive systems
2. Individuals with cardiovascular disease (such as unstable angina, myocardial infarction, or severe heart failure)
3. Individuals undergoing hormone therapy or taking ED medications
Target Size - 10
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 31 Day
Date of IRB - 2026 Year 09 Month 14 Day
Anticipated trial start date - 2026 Year 09 Month 16 Day
Last follow-up date - 2026 Year 10 Month 07 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072057
Disclaimer: Curated by HT Syndication.
